tirzepatide surpass-5 SURPASS to SURMOUNT: The Trials To Know Efficacy and Safety of Tirzepatide

But the actual numbers differ because tirzepatide and semaglutide come in different concentrations and use different dose ranges

Vernon, S

Fatigue is most common at two specific points

Diabetol Metab Syndr 15(1):101 [DOI] [PMC free article] [PubMed] Alrouji M et al (2024) Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: a new perspective

Mounjaro significantly reduced HbA1c levels in 5 clinical trials (source: Lilly website) Obesity was common among clinical trial participants, with most participants having a BMI between 32 and 34 at enrollment

Our study aims to explore the relationship between GLP-1 RA and the development of SIBO